{
  "resourceType": "ServiceRequest",
  "id": "mii-exa-molgen-anforderung-fgfr2-fusion",
  "meta": {
    "profile": [
      "https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/anforderung-genetischer-test"
    ]
  },
  "identifier": [
    {
      "system": "https://www.charite.de/fhir/auftragsnummern",
      "value": "PRK4QE59A"
    }
  ],
  "status": "active",
  "intent": "order",
  "category": [
    {
      "coding": [
        {
          "code": "108252007",
          "system": "http://snomed.info/sct",
          "display": "Laboratory procedure (procedure)"
        }
      ]
    }
  ],
  "code": {
    "coding": [
      {
        "code": "405825005",
        "system": "http://snomed.info/sct",
        "display": "Molecular genetic test (procedure)"
      }
    ],
    "text": "Therapierelevante genetische Ver√§nderungen bei Intrahepatischem Gallengangskarzinom"
  },
  "subject": {
    "reference": "Patient/mii-exa-molgen-patient-fgfr2-fusion"
  },
  "authoredOn": "2022-11-30",
  "requester": {
    "reference": "Practitioner/mii-exa-molgen-practitioner-physician"
  },
  "reasonCode": [
    {
      "coding": [
        {
          "code": "109842005",
          "system": "http://snomed.info/sct",
          "display": "Intrahepatic bile duct carcinoma (disorder)"
        },
        {
          "code": "C22.1",
          "system": "http://fhir.de/CodeSystem/bfarm/icd-10-gm",
          "version": "2022",
          "display": "Intrahepatisches Gallengangskarzinom"
        }
      ]
    }
  ]
}
